1 recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Metabolic Disorders: new trials by email Literature Review of Metabolic Disorders trials Research Report on Metabolic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting Orforglipron - Diabetes Mellitus, Type 2, Diabetes Melletus | Phase 3 | Recruiting | Eli Lilly and Company | 130 | 2026-07-15 | 2026-10-08 |
| Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients Heparin, Normal saline - Childhood Cancer, Aplastic Anemia | Phase 3 | Terminated | Alberta Children's Hospital | 2 | 2011-04-01 | 2012-05-30 |
Metabolic Diseases (2) · Anemia, Aplastic (1) · Behavior (1) · Diabetes Mellitus, Type 2 (1) · Endocrine System Diseases (1) · Fasting (1) · Feeding Behavior (1) · Glucose Metabolism Disorders (1) · Neoplasms (1) · Nutritional and Metabolic Diseases (1)
Anemia (1) · Behavior, Animal (1) · Bone Marrow Diseases (1) · Bone Marrow Failure Disorders (1) · Diabetes Mellitus (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Nutritional and Metabolic Diseases (1)
Heparin (1) · Saline Solution (1) · orforglipron (1)
Alberta Children's Hospital (1) · Eli Lilly and Company (1)
Canada (1) · India (1) · Saudi Arabia (1) · South Africa (1) · United Arab Emirates (1)